However, HDL-C displayed a decreasing trend from quartile 1 to quartile 4 ( P < 0.001; Table 2 ).
← all phrases
“a decreasing trend”
Sighted at
p=0.09
In the literature
Additionally, the c value at ME6.28 showed a decreasing trend compared to other levels of ME ( P < 0.001).
Results The serum levels of 25(OH)D, 25(OH)D3, and F25(OH)D showed a decreasing trend ( z = −2.781–−3.996, P < 0.01) in RA patients with CKD progression from mild to severe, while C3-epi-25(OH)D3 showed an increasing trend ( z = 6.741, P < 0.001) and 25(OH)D2 showed no significant difference among the groups ( z = 0.976, P = 0.329).
There was a decreasing trend in syphilis incidences among 4907 HIV-infected patients from the first year through the 11 th year after HIV diagnosis ( β = -0.01, P = .001).
TCD showed a decreasing trend with the increasing N:P ratio (Fig. 1 c), which had a significant difference among the treatments ( p = 0.001, Table 1 ), while the RCD of C. filispica showed a positive correlation and increased ( r = 0.363, Table 1 ).
A decreasing trend in MTR values across levels was found for whole WM ( r = −0.2, p < 0.001).
Among HBM-related constructs, there was a decreasing trend for the prevalence of barriers, from its highest peak in July 2015 (56.2%) to the lowest prevalence in October 2018 (28.4%; difference, 27.8%; P < .001).
From 2006 through 2017, the proportion of cases of intentional injury showed a decreasing trend (z = 22.7, P < 0.001) (Figure 1 ).
Although SFC showed a decreasing trend over time at all three time points, numbers remained higher than for the PBS group ( p < 0.001, p = 0.0059 and p < 0.001, Figure 3 A) and the non-adjuvanted gE experimental vaccine group ( p = 0.0009, p = 0.0457, and p = 0.0008, Figure 3 A) at the same time point.
Temporal trends of unintentional injury mortality by age groups In the 0–4 age group, the unintentional injury mortality rate had a decreasing trend in males (AAPC=–4.6%, p<0.001) and females (AAPC=–6.8%, p<0.001).
Moreover, the IOD of GFAP showed a decreasing trend over time in the control and MSC groups [control group: dpo 7 (8.59 × 10 6 ) vs. dpo 28 (3.42 × 10 6 ), p < 0.001; MSC group: dpo 7 (8.84 × 10 6 ) vs. dpo 28 (3.87 × 10 6 ), p < 0.001], while its IOD was slightly increased over time in the NSC group, but these differences were not significantly [dpo 7 (3.69 × 10 5 ), dpo 14 (9.98 × 10 5 ), dpo 28 (1.89 × 10 6 )].
Correlation analysis between the frequency of CD4 + and CD8 + MAIT cells demonstrated that as the percentage of CD4 + MAIT cells increased, the frequency of CD8 + MAIT cells exhibited a decreasing trend in the OLP group ( r = -0.5682, p < 0.001, n = 40, Fig. 2 D).
We observed a decreasing trend in both procedures during the study period ( P < 0.001).
V yolk /V egg (where V yolk in this figure is the yolk excluding the embryo volume) consistently showed a decreasing trend (all occasions, p <0.001) ( Figure 2C ).
The distribution of these variables has changed over time. As displayed in Table 1 , the Primary purpose of trials oriented toward treatment comprised the largest proportion (60.0%) of interventional trials listed, while the proportion showed a decreasing trend over time ( Z = − 16.12, p < 0.001).
Like structural parameters, all neuropsychological variables showed a decreasing trend with advancing stage ( p < 0.001).
From 2007 to 2017, the rate of inpatient care days ( Figure 3B ) showed a significant increase in the study area (city of Oulu) (AAPC = 0.9; 95% confidence interval = 0.6–1.2; p < 0.001) compared with a decreasing trend in Finland (AAPC = −4.6; 95% confidence interval = −5.0 to −4.3; p < 0.001).
The prevalence of advanced fibrosis in each quartile (Q 1 –Q 4 ) showed a decreasing trend as muscle strength increased ( Figure 3 ): Fibrosis FIB4 , 18.0% (SE 1.6%), 11.2% (SE, 1.4%), 8.0% (SE, 1.4%), and 2.6% (SE, 1.0%) ( P < 0.001); Fibrosis BARD , 63.9% (SE, 2.3%), 50.3% (SE, 2.4%), 42.4% (SE, 2.6%), and 29.7% (SE, 4.6%) ( P < 0.001).
A final change occurs in 2016 (p<0.001, Supremum Wald statistic=165.08), followed by a decreasing trend (beta coefficient: −0.66 (95% CI −0.88 to –0.44), p<0.001).
It was observed that there was a significant increasing trend in RSA rates and a decreasing trend in HA and TSA rates over time (p < 0.001).
By linear and linear association, there was a decreasing trend of the hypoparathyroidism (PTH<10 pg/mL) over time ( p <0.001).
Amoxicillin, pivmecillinam, and trimethoprim also showed a decrease in antibiotic resistance over the six years (a decreasing trend of 2.74% (p <0.001), 6.25% (p <0.001) and 2.54% (p <0.001) per year respectively).
Total dissolved solids and absorbance measurements exhibited a decreasing trend with increasing concentration (effect size = 0.87, p < 0.001 ), supporting an inhibitory effect under the tested conditions.
Female admissions showed a decreasing trend from 2000 to 2005 (slope -22.508, 95% CI -30.518 to -14.497, SE 2.885, adjusted R 2 0.923, F 60.861, P = 0.001).
There was also a decreasing trend toward diabetes risk when baseline BRI more than 5.24 reversed to <5.24 at follow-up (HR = 1.56; 95% CI, 1.23, 1.98; P < 0.001) compared with those whose BRI remained more than 5.24 at follow-up (HR = 1.95; 95% CI, 1.63, 2.32; P < 0.001).